CORE
🇺🇦Â
 make metadata, not war
Services
Services overview
Explore all CORE services
Access to raw data
API
Dataset
FastSync
Content discovery
Recommender
Discovery
OAI identifiers
OAI Resolver
Managing content
Dashboard
Bespoke contracts
Consultancy services
Support us
Support us
Membership
Sponsorship
Community governance
Advisory Board
Board of supporters
Research network
About
About us
Our mission
Team
Blog
FAQs
Contact us
Patients' Understanding of How Genotype Variation Affects Benefits of Tamoxifen Therapy for Breast Cancer
Authors
N.T. Brewer
L.A. Carey
+14Â more
D.R. Carrizosa
W.K. Chiu
S.W. Corso
J.T. DeFrank
J.G. Ibrahim
W.J. Irvin
H.L. McLeod
S.G. Moore
O.A. Olajide
J.M. Peppercorn
R.E. Raab
P. Rubin
G. Schwartz
C.M. Walko
Publication date
1 January 2014
Publisher
Doi
Cite
View
on
PubMed
Abstract
CYP2D6 is a critical enzyme in the metabolism of tamoxifen and potentially a key determinant in breast cancer outcomes. Our study examined patients' beliefs about how CYP2D6 genotype would affect their prognoses
Similar works
Full text
Open in the Core reader
Download PDF
Available Versions
Carolina Digital Repository
See this paper in CORE
Go to the repository landing page
Download from data provider
cdr.lib.unc.edu:4q77g062p
Last time updated on 24/11/2020
King's Research Portal
See this paper in CORE
Go to the repository landing page
Download from data provider
oai:kclpure.kcl.ac.uk:publicat...
Last time updated on 28/09/2023
Crossref
See this paper in CORE
Go to the repository landing page
Download from data provider
info:doi/10.1159%2F000356565
Last time updated on 05/06/2019